Navigation Links
Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Date:11/29/2007

CALGARY, Nov. 29 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that Dr. Matt Coffey, Chief Scientific Officer of Oncolytics, is scheduled to deliver a presentation on Wednesday, December 5, 2007 entitled "Large Scale Production Process for the Oncolytic Agent REOLYSIN(R) (Human Reovirus)" at the Informa Life Sciences' 3rd Annual Vaccine Production Conference in Cologne, Germany. The conference runs from December 4-5, 2007.
For more information about the conference, please visit

http://www.informa-ls.com/vaccines.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the manufacturing process presented at this conference, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's abilit
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/--Reportlinker.comannouncesthatanewmarket...azilBioethanolMarketAnalysisandForecaststo2013 ,...ioethanol-Market-Analysis-and-Forecasts-to-2013.ht...tsto2013 ,, Summary ,, Thereportprovidesde...ketandtheBrazilbioethanolmarketinparticular.Italso...
(Date:11/24/2009)... The New York investment bank KTA Capital,s client...n AU$6.7 mil convertible note private placement wi...ement was arranged by KTA Capital as Neuren,s excl... New York (PRWEB) November 23, 2009 -- ...al, LLC ("KTA Capital") has announced th...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in O... consistent growth during the U.S. recession. Howe...uble, and health systems are coming closer to havi...ust administrators. , (Vo...ontinued growing in October despite the shedding o...
(Date:11/24/2009)...Newswire/--BlueMarbleEnergyCorp.announcedtodaythat...PDA)wererecentlyawarded$2millionbyWashingtonState,...ate/publicpartnershiptoconstructthestate,sfirstspe..., "Thisinvestmentwillsignificantlyspeedthedevelo...olnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."We...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
..., J. Chartier and H.C. Birnboim , ..., DNA collected with Oragene works well w...in the thymidylate synthetase and apolipoprotein E... , Introduction , Single-nuc...and are estimated , to occur at 1 out of ...
..., J. Chartier , DNA Genotek Inc.,...lected with Oragene is successfully amplified usin...nd has the potential to generate near-unlimited ,...nts. , , Introduction , ...phisms (SNPs) becomes more , automated an...
Unique Histochemical Substrate Permits Dual Staining In Animal Tissue
Other Biology Technology:Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3Oragene and Whole Genome Amplification with GenomiPhi 2Oragene and Whole Genome Amplification with GenomiPhi 3Oragene and Whole Genome Amplification with GenomiPhi 4
(Date:11/25/2009)...tate University assistant professors recently rece...(NSF) to continue research beneficial to understan...000. , Christopher Blackwood, assistant professo...arded grants to support two separate research proj...tter Decomposer Communities and Functions from the...
(Date:11/24/2009)...nds of years it has been prescribed by traditional...om headaches and stomach pain to fever and flu. ,...University have been able to scientifically prove ... otherwise known as Brazilian mint. , Testing thi...d by researcher Graciela Rocha was able to show th...
(Date:11/24/2009)...ence is opening new doors to understanding how sou...aring of a marine mammal or if they hear it at al...ay scanners that NASA uses to detect flaws in the ... allowing scientists to peek inside the giant head...e-dimensional replicas of a whale,s hearing anatom...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Drake Center is Site for 243 6 Million NIH Grant to Study Mental Rehearsal that Improves Motor Skills in Stroke Patients 60443 1Drake Center is Site for 243 6 Million NIH Grant to Study Mental Rehearsal that Improves Motor Skills in Stroke Patients 60443 2Drake Center is Site for 243 6 Million NIH Grant to Study Mental Rehearsal that Improves Motor Skills in Stroke Patients 60443 3AARP Commends Legislature For Saving Critical Health Care Program 60438 1Health of Subzero 1992 Winner of Melbourne Cup Threatened After Customs Mix Up 60433 1Health of Subzero 1992 Winner of Melbourne Cup Threatened After Customs Mix Up 60433 2Health of Subzero 1992 Winner of Melbourne Cup Threatened After Customs Mix Up 60433 3
...e when everything was big has helped Queensland re...nge, instead of humans, was responsible for wiping...00 years ago. , Instead of only excavating ,troph...the researchers from Queensland University of Tech...irst systematic analysis of a site in the fossil r...
...enetic disorder called Krabbe disease can be saved...eive stem cells from umbilical cord blood before s...dy published in the May 19, 2005, issue of the New...te transplant of stem cells, Krabbe infants rapidl...and die by the age of two, said the researchers. T...
...mpossible to accurately measure the levels of impo... and at the level of a single cell. Scientists at ...logy and Stanford University are the first to over...c nanotechnology using molecular sensors to view c... their 3-dimensional form upon binding with the ch...
Other Biology News:Small species back-up giant marsupial climate change extinction claim 2Small species back-up giant marsupial climate change extinction claim 3Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells 2Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells 3Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells 4Revolutionary nanotechnology illuminates brain cells at work 2Revolutionary nanotechnology illuminates brain cells at work 3
...re designed for full-length gene cloning and requi... cDNA clone. The first PCR analysis is performed i...ns plasmid DNA from 5,000 clones. Having identifie...he reaction products, the second PCR analysis is c...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...r calibrating single-channel and multi-channel pip...st carrying case, the MCP1-S is ideal for calibrat... the users premises. The unit is extremely easy to...tomatically. Multi-channel pipettes can therefore ...
Cleland’s Reagent, Molecular Biology Grade from Calbiochem
Biology Products: